Myeloid Neoplasm Post Cytotoxic Therapy

Myeloid Neoplasm Post Cytotoxic Therapy — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 24.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04518345	TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia	completed	Early Phase 1	3	Uma BorateOTHER	1	Feb 6, 2023	clinicaltrials

Data updated 22 days agoSource updated Feb 6, 2023source: clinicaltrials